Shih-Feng Cho

10PUBLICATIONS

18CO-AUTHORS

Predictive and prognostic markersMulticultural, intercultural and cross-cultural studiesMolecular targetsHaematological tumoursAutoimmunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 20, 2026

Baseline FDG PET/CT SUVmax predicts POD24 and progression-free survival in newly diagnosed follicular lymphoma.

|May 13, 2026

Adverse Reactions and Vaccination Preferences Following COVID-19 and Influenza Vaccination Among Healthcare Workers: A Cross-Sectional Survey.

|Oct 31, 2025

Targeting lncRNA MALAT1 attenuates lenalidomide resistance via CD38 epigenetic modulation, oxidative stress-mediated cell death, and remodeling of the pro-tumor microenvironment in multiple myeloma.

Wen-Hsin Chang, Wei-Ting Liao, Tsung-Jang Yeh

|Aug 26, 2023

High G9a Expression in DLBCL and Its Inhibition by Niclosamide to Induce Autophagy as a Therapeutic Approach.

Chin-Mu Hsu, Kung-Chao Chang, Tzer-Ming Chuang

|Jun 29, 2023

Diagnostic challenges in plasma cell myeloma with lymphoplasmacytic lymphoma-feature.

Min-Hong Wang, Chun-Chieh Wu, Shih-Feng Cho

|Oct 11, 2021

Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma.

Hui-Ching Wang, Hui-Hua Hsiao, Jeng-Shiun Du

Pageof 2

Frequent Collaborators

Hui-Hua Hsiao

Hui-Ching Wang

Jeng-Shiun Du

Tsung-Jang Yeh

Tzer-Ming Chuang

Chin-Mu Hsu

Yuh-Ching Gau

Ya-Lun Ke

Sin-Hua Moi

Min-Hong Wang

Frequent Collaborators

Hui-Hua Hsiao

Hui-Ching Wang

Jeng-Shiun Du

Tsung-Jang Yeh